Elli Peselev

Array ( [id] => 6736031 [patent_doc_number] => 20030013666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Injectable ready-to-use solutions containing an antitumor anthracycline glycoside' [patent_app_type] => new [patent_app_number] => 09/902030 [patent_app_country] => US [patent_app_date] => 2002-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11640 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20030013666.pdf [firstpage_image] =>[orig_patent_app_number] => 09902030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1413756 [patent_doc_number] => 06528628 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-04 [patent_title] => 'Erythromycin a compounds and process for preparing the same' [patent_app_type] => B1 [patent_app_number] => 09/869559 [patent_app_country] => US [patent_app_date] => 2001-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6222 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/528/06528628.pdf [firstpage_image] =>[orig_patent_app_number] => 09869559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1107921 [patent_doc_number] => 06809080 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-10-26 [patent_title] => 'Macrolide antibiotics' [patent_app_type] => B2 [patent_app_number] => 09/892081 [patent_app_country] => US [patent_app_date] => 2001-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7444 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/809/06809080.pdf [firstpage_image] =>[orig_patent_app_number] => 09892081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6408176 [patent_doc_number] => 20020037864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => '2\'-Propionate clarithromycin dodecyl sulfate and its preparation and pharmaceutical composition containing the same' [patent_app_type] => new [patent_app_number] => 09/886390 [patent_app_country] => US [patent_app_date] => 2001-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3556 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20020037864.pdf [firstpage_image] =>[orig_patent_app_number] => 09886390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 715875 [patent_doc_number] => 07053061 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-30 [patent_title] => 'Amphotercin B structured emulsion' [patent_app_type] => utility [patent_app_number] => 10/312298 [patent_app_country] => US [patent_app_date] => 2001-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 13113 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/053/07053061.pdf [firstpage_image] =>[orig_patent_app_number] => 10312298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1246247 [patent_doc_number] => 06677435 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-01-13 [patent_title] => 'Prodrug activation using catalytic antibodies' [patent_app_type] => B2 [patent_app_number] => 09/883758 [patent_app_country] => US [patent_app_date] => 2001-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10797 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/677/06677435.pdf [firstpage_image] =>[orig_patent_app_number] => 09883758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 782820 [patent_doc_number] => 06992068 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-01-31 [patent_title] => 'Cytokine production inhibitors, agents for protecting and promoting liver function, anti-inflammatory agents, immunosuppressants, drugs, cosmetics, foods and food materials' [patent_app_type] => utility [patent_app_number] => 10/311136 [patent_app_country] => US [patent_app_date] => 2001-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11045 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/992/06992068.pdf [firstpage_image] =>[orig_patent_app_number] => 10311136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1550862 [patent_doc_number] => 06399580 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => 'Methods and compositions for stimulating tissue growth and epithelial moisturization' [patent_app_type] => B1 [patent_app_number] => 09/879402 [patent_app_country] => US [patent_app_date] => 2001-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 33 [patent_no_of_words] => 8164 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399580.pdf [firstpage_image] =>[orig_patent_app_number] => 09879402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6509792 [patent_doc_number] => 20020025938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-28 [patent_title] => 'Macrolide intermediates in the preparation of clarithromycin' [patent_app_type] => new [patent_app_number] => 09/877778 [patent_app_country] => US [patent_app_date] => 2001-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4200 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20020025938.pdf [firstpage_image] =>[orig_patent_app_number] => 09877778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6622350 [patent_doc_number] => 20020065253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-30 [patent_title] => 'Use of growth factor modulating compounds' [patent_app_type] => new [patent_app_number] => 09/876637 [patent_app_country] => US [patent_app_date] => 2001-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9293 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20020065253.pdf [firstpage_image] =>[orig_patent_app_number] => 09876637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7367457 [patent_doc_number] => 20040006046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Malto-oligosaccharide derivatives and use thereof' [patent_app_type] => new [patent_app_number] => 10/297408 [patent_app_country] => US [patent_app_date] => 2002-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4284 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20040006046.pdf [firstpage_image] =>[orig_patent_app_number] => 10297408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6693061 [patent_doc_number] => 20030040493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-27 [patent_title] => 'Water-soluble amide derivatives of polyene macrolides and preparation and uses thereof' [patent_app_type] => new [patent_app_number] => 09/870071 [patent_app_country] => US [patent_app_date] => 2001-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20765 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20030040493.pdf [firstpage_image] =>[orig_patent_app_number] => 09870071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6033415 [patent_doc_number] => 20020019369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-14 [patent_title] => 'Injectable drug delivery systems with cyclodextrin-polymer based hydrogels' [patent_app_type] => new [patent_app_number] => 09/861182 [patent_app_country] => US [patent_app_date] => 2001-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3663 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20020019369.pdf [firstpage_image] =>[orig_patent_app_number] => 09861182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1376061 [patent_doc_number] => 06562953 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-05-13 [patent_title] => 'Process which is useful for converting the carbonyl function in position 4 of the cladinose unit of an aza-macrolide into an amine derivative' [patent_app_type] => B2 [patent_app_number] => 09/858671 [patent_app_country] => US [patent_app_date] => 2001-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4663 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/562/06562953.pdf [firstpage_image] =>[orig_patent_app_number] => 09858671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1388057 [patent_doc_number] => 06548485 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-04-15 [patent_title] => 'Stable antitumor drug' [patent_app_type] => B2 [patent_app_number] => 09/854257 [patent_app_country] => US [patent_app_date] => 2001-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1493 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/548/06548485.pdf [firstpage_image] =>[orig_patent_app_number] => 09854257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1355700 [patent_doc_number] => 06576617 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-06-10 [patent_title] => 'Direct action anti-mycotic' [patent_app_type] => B2 [patent_app_number] => 09/853312 [patent_app_country] => US [patent_app_date] => 2001-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7789 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/576/06576617.pdf [firstpage_image] =>[orig_patent_app_number] => 09853312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 679198 [patent_doc_number] => 07083806 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-01 [patent_title] => 'Wound gels' [patent_app_type] => utility [patent_app_number] => 10/275771 [patent_app_country] => US [patent_app_date] => 2001-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10334 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/083/07083806.pdf [firstpage_image] =>[orig_patent_app_number] => 10275771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7451559 [patent_doc_number] => 20040010128 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Cost effective method for selective methylation of erythromycin a derivatives' [patent_app_type] => new [patent_app_number] => 10/276505 [patent_app_country] => US [patent_app_date] => 2003-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1740 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20040010128.pdf [firstpage_image] =>[orig_patent_app_number] => 10276505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5846376 [patent_doc_number] => 20020133048 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'Converting sugars to sugar alcohols by aqueous phase catalytic hydrogenation' [patent_app_type] => new [patent_app_number] => 09/845646 [patent_app_country] => US [patent_app_date] => 2001-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6701 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0133/20020133048.pdf [firstpage_image] =>[orig_patent_app_number] => 09845646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6898316 [patent_doc_number] => 20010046481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-29 [patent_title] => 'Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)' [patent_app_type] => new [patent_app_number] => 09/842514 [patent_app_country] => US [patent_app_date] => 2001-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6913 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20010046481.pdf [firstpage_image] =>[orig_patent_app_number] => 09842514 [rel_patent_id] =>[rel_patent_doc_number] =>)